Early detection Opportunity to position saliva-based infection detection as a rapid screening tool for organizations with high-risk or frontline staff, leveraging our device's pre-symptomatic and asymptomatic detection to reduce downtime and improve workforce health.

Defense collaboration Leverage the existing collaboration with the US Department of Defense to explore government or defense procurement channels, emphasizing national security benefits and validated performance to win funded pilot programs.

Small team agility Target strategic partnerships with mid-to-large labs and specialty clinics that can act as early adopters, offering turnkey deployment and support that fits a small company’s agility and customer service capabilities.

Cloud and data fit Highlight compatibility with major cloud and identity platforms (Azure AD, Google Cloud) to offer secure data capture, remote monitoring, and compliance-driven workflows appealing to enterprise customers and regulated industries.

Scale-ready value Present total cost of ownership and return-on-investment scenarios that compare the handheld device to lab-based testing, focusing on reduced turnaround time, minimized supply chain dependencies, and potential for multi-site deployment.